• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于精神疾病患者阿片类药物使用障碍药物治疗的观点。

Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness.

机构信息

Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, USA.

Department of Family Medicine, David Geffen School of Medicine at UCLA, 10880 Wilshire Blvd., Suite 1800, Los Angeles, CA, 90024, USA.

出版信息

Community Ment Health J. 2023 Feb;59(2):345-356. doi: 10.1007/s10597-022-01012-x. Epub 2022 Jul 29.

DOI:10.1007/s10597-022-01012-x
PMID:35906435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9859922/
Abstract

Most people with co-occurring opioid use disorder (OUD) and mental illness do not receive effective medications for treating OUD. To investigate perspectives of adults in a publicly-funded mental health system regarding medications for OUD (MOUD), we conducted semi-structured telephone interviews with 13 adults with OUD (current or previous diagnosis) receiving mental health treatment. Themes that emerged included: perceiving or using MOUDs as a substitute for opioids or a temporary solution to prevent withdrawal symptoms; negative perceptions about methadone/methadone clinics; and viewing MOUD use as "cheating". Readiness to quit was important for patients to consider MOUDs. All participants were receptive to discussing MOUDs with their mental health providers and welcomed the convenience of receiving care for their mental health and OUD at the same location. In conclusion, clients at publicly-funded mental health clinics support MOUD treatment, signaling a need to expand access and build awareness of MOUDs in these settings.

摘要

大多数同时患有阿片类药物使用障碍(OUD)和精神疾病的人并未接受有效的 OUD 治疗药物。为了调查公共资助的精神卫生系统中的成年人对阿片类药物使用障碍治疗药物(MOUD)的看法,我们对 13 名接受精神卫生治疗的患有 OUD(当前或以前的诊断)的成年人进行了半结构化电话访谈。出现的主题包括:将 MOUD 视为阿片类药物的替代品或预防戒断症状的临时解决方案;对美沙酮/美沙酮诊所的负面看法;以及将 MOUD 用药视为“作弊”。准备戒断对于患者考虑 MOUD 很重要。所有参与者都愿意与他们的精神卫生提供者讨论 MOUD,并欢迎在同一地点同时接受他们的精神健康和 OUD 护理的便利性。总之,公共资助的精神卫生诊所的客户支持 MOUD 治疗,表明需要在这些环境中扩大 MOUD 的获取途径并提高对 MOUD 的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ec/9859922/7d403f9531aa/10597_2022_1012_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ec/9859922/efd31af00e3f/10597_2022_1012_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ec/9859922/7d403f9531aa/10597_2022_1012_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ec/9859922/efd31af00e3f/10597_2022_1012_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ec/9859922/7d403f9531aa/10597_2022_1012_Fig2_HTML.jpg

相似文献

1
Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness.关于精神疾病患者阿片类药物使用障碍药物治疗的观点。
Community Ment Health J. 2023 Feb;59(2):345-356. doi: 10.1007/s10597-022-01012-x. Epub 2022 Jul 29.
2
Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter.评估关于阿片类药物使用障碍和纳洛酮药物在 Twitter 上的认知。
J Addict Dis. 2021 Jan-Mar;39(1):37-45. doi: 10.1080/10550887.2020.1811456. Epub 2020 Aug 24.
3
A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.一种混合方法比较了医生对阿片类药物使用障碍药物治疗的信念和障碍的报告。
Subst Abuse Treat Prev Policy. 2020 Sep 14;15(1):69. doi: 10.1186/s13011-020-00312-3.
4
Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: An interrupted time series analysis.加拿大温哥华 COVID-19 大流行对阿片类药物使用障碍(MOUD)药物治疗入组的影响:一项中断时间序列分析。
Int J Drug Policy. 2023 Aug;118:104075. doi: 10.1016/j.drugpo.2023.104075. Epub 2023 May 22.
5
Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.在同时存在物质使用问题的退伍军人中治疗阿片类药物使用障碍:在初级保健、心理健康和疼痛环境中使用丁丙诺啡的提供者的定性研究。
Addict Sci Clin Pract. 2023 May 4;18(1):26. doi: 10.1186/s13722-023-00382-1.
6
"Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness.“厌倦了生病和疲惫”:探索在无家可归者中开始使用治疗阿片类药物使用障碍的药物。
J Subst Abuse Treat. 2022 Jul;138:108752. doi: 10.1016/j.jsat.2022.108752. Epub 2022 Feb 23.
7
Attitudes toward and training in medications for opioid use disorders: a descriptive analysis among employees in the youth legal system and community mental health centers.对阿片类药物使用障碍药物的态度和培训:青年法律系统和社区心理健康中心员工中的描述性分析。
Subst Abuse Treat Prev Policy. 2024 Jun 21;19(1):32. doi: 10.1186/s13011-024-00614-w.
8
Prescribing and Acceptance of Medications for Opioid Use Disorder in VA Primary Care: Veteran and Provider Perspectives.VA 初级保健中阿片类药物使用障碍的药物处方和接受情况:退伍军人和提供者的观点。
J Gen Intern Med. 2024 Jul;39(9):1690-1697. doi: 10.1007/s11606-024-08703-z. Epub 2024 Apr 8.
9
Massachusetts Justice Community Opioid Innovation Network (MassJCOIN).马萨诸塞州司法社区阿片类药物创新网络(MassJCOIN)。
J Subst Abuse Treat. 2021 Sep;128:108275. doi: 10.1016/j.jsat.2021.108275. Epub 2021 Jan 8.
10
Impact of Perceived Access and Treatment Knowledge on Medication Preferences for Opioid Use Disorder.感知可及性和治疗知识对阿片类药物使用障碍药物治疗偏好的影响。
Subst Use Addctn J. 2024 Oct;45(4):706-715. doi: 10.1177/29767342241254591. Epub 2024 Jun 3.

本文引用的文献

1
Unmet Need in Relation to Mental Healthcare and Past-Month Drug Use among People with Mental Illness in the United States.美国精神疾病患者精神卫生保健和过去一个月药物使用的未满足需求。
J Psychoactive Drugs. 2022 Jul-Aug;54(3):241-249. doi: 10.1080/02791072.2021.1962577. Epub 2021 Aug 17.
2
Opioid Use Disorder Among Clients of Community Mental Health Clinics: Prevalence, Characteristics, and Treatment Willingness.社区心理健康诊所患者中的阿片类药物使用障碍:患病率、特征和治疗意愿。
Psychiatr Serv. 2022 Mar 1;73(3):271-279. doi: 10.1176/appi.ps.202000818. Epub 2021 Jul 20.
3
The association of opioid use disorder and homelessness nationally in the veterans health administration.
全美退伍军人健康管理局阿片类药物使用障碍与无家可归的关联。
Drug Alcohol Depend. 2021 Jun 1;223:108714. doi: 10.1016/j.drugalcdep.2021.108714. Epub 2021 Apr 14.
4
A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.对患者和医疗服务提供者关于阿片类物质使用障碍治疗药物观点的系统评价。
J Subst Abuse Treat. 2020 Dec;119:108146. doi: 10.1016/j.jsat.2020.108146. Epub 2020 Sep 22.
5
Treatment receipt patterns among individuals with co-occurring posttraumatic stress disorder (PTSD) and substance use disorders.共病创伤后应激障碍(PTSD)和物质使用障碍个体的治疗接受模式。
J Consult Clin Psychol. 2020 Nov;88(11):1039-1051. doi: 10.1037/ccp0000600. Epub 2020 Aug 13.
6
Attitudes about medications for alcohol use disorder among individuals with serious mental illness: A health belief model analysis.严重精神疾病患者对酒精使用障碍药物治疗的态度:健康信念模型分析
J Subst Abuse Treat. 2020 Jul;114:108007. doi: 10.1016/j.jsat.2020.108007. Epub 2020 Apr 20.
7
Barriers and Facilitators to Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine.临床医生准备在急诊科提供丁丙诺啡的障碍和促进因素。
JAMA Netw Open. 2020 May 1;3(5):e204561. doi: 10.1001/jamanetworkopen.2020.4561.
8
Willingness to take buprenorphine/naloxone among people who use opioids in Vancouver, Canada.加拿大温哥华地区阿片类药物使用者服用丁丙诺啡/纳洛酮的意愿。
Drug Alcohol Depend. 2019 Dec 1;205:107672. doi: 10.1016/j.drugalcdep.2019.107672. Epub 2019 Oct 25.
9
Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder.比较一组患有阿片类药物使用障碍的白人个体开始和停止美沙酮、丁丙诺啡和纳曲酮治疗的原因。
J Addict Med. 2020 Jul/Aug;14(4):e44-e52. doi: 10.1097/ADM.0000000000000584.
10
"Everything is not right anymore": Buprenorphine experiences in an era of illicit fentanyl.“一切都不再正常了”:非法芬太尼时代的丁丙诺啡体验。
Int J Drug Policy. 2019 Dec;74:76-83. doi: 10.1016/j.drugpo.2019.09.003. Epub 2019 Sep 25.